Review Article
Therapeutics of Diabetes Mellitus: Focus on Insulin Analogues and Insulin Pumps
Table 1
Main characteristics of rapid and long-acting insulin analogues.
| Analogue | Trade name/manufacturer | Onset (min) | Peak (hrs) | Duration (hrs) |
| Long-acting analogues | | | | | Glargine | Lantus/Sanofi-Aventis | 4–6 hrs | No peak | 24 hrs | Detemir | Levemir/Novo Nordisk | 4–6 hrs | 8–10 hrs | 17 hrs | Rapid-acting analogues | | | | | Lispro | Humalog/Eli Lilly | 15–30 min | 0.5–2.5 hrs | 3–6.5 hrs | Aspart | Novorapid/Novo Nordisk | 10–20 min | 1–3 hrs | 3–5 hrs | Glulisine | Apidra/Sanofi-Aventis | 10–15 min | 1–1.5 hrs | 3–5 hrs |
|
|